Method Peptides · Research compound

Tirzepatide

$80.00
Dose: 10mg
≥99% purity
Third-party tested
Ships from the USA
Secure, discreet packaging
ShippingFree on orders $200+

$15 flat rate on orders under $200.

FulfillmentEstimated 2–5 business days

Tracking is provided when the order ships.

Review return policy →

Research reference

Compound overview

Product specifications, research context, and handling information.

Tirzepatide

Tirzepatide is a synthetic peptide that activates GIP and GLP-1 receptors and is studied in incretin and metabolic signaling research.

Experimental models examine glucose-dependent signaling, receptor responses, nutrient sensing, and communication between incretin pathways.

Key Research Areas

  • GIP receptor activity
  • GLP-1 receptor signaling
  • Glucose-response models
  • Comparative incretin pharmacology

Mechanism of Interest

Tirzepatide engages both GIP and GLP-1 receptors. Researchers measure downstream receptor signaling and endocrine responses to distinguish the contributions of each pathway.

Product Details

Format: Lyophilized material in vial format
Available Options: 10 mg per vial
Compound Class: Synthetic peptide; dual GIP/GLP-1 receptor agonist
Compound: Tirzepatide
Storage: Follow the product label and lot-specific storage instructions. Prepared-sample storage depends on formulation and validated laboratory stability conditions.

The Dual-Incretin Connection

GIP and GLP-1 both contribute to the body's response to nutrients. Tirzepatide research examines how activating both receptors changes metabolic signaling and how each pathway contributes to the combined response.

Research Use Only:

This product is intended strictly for laboratory and research purposes. Not for human consumption, medical use, diagnostic use, or therapeutic use.